Back
Janux Therapeutics Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
JANX
Janux Therapeutics
Last Price:
$27.03
Seasonality Move:
-4.46%
7 Day Trial
ALL ACCESS PASS
$
7

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.2 | Sell |
20-day SMA: | 30.17 | Sell |
50-day SMA: | 35.24 | Sell |
200-day SMA: | 44.55 | Sell |
8-day EMA: | 28.76 | Sell |
20-day EMA: | 30.46 | Sell |
50-day EMA: | 35.27 | Sell |
200-day EMA: | 40.97 | Sell |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.08 | Sell |
Relative Strength Index (14 RSI): | 37.42 | Sell |
Chaikin Money Flow: | 417699 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.01 - 32.01) | Sell |
Bollinger Bands (100): | (33.52 - 55.34) | Sell |
Janux Therapeutics Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 28.25 while JANX 8-day simple moving average is 29.20, which is a Sell signal.
-
The stock price of JANX is 28.25 while Janux Therapeutics 20-day SMA is 30.17, which makes it a Sell.
-
Janux Therapeutics 50-day simple moving average is 35.24 while JANX share price is 28.25, making it a Sell technically.
-
JANX stock price is 28.25 and Janux Therapeutics 200-day simple moving average is 44.55, creating a Sell signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
42
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a SellThe current Janux Therapeutics [JANX] share price is $28.25. The Score for JANX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
1.7B
Price in USD:
28.25
Share Volume:
713.1K
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
26.03
Sell
42
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 28.25 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 28.25 while JANX 8-day exponential moving average is 28.76, which is a Sell signal.
-
The stock price of JANX is 28.25 while Janux Therapeutics 20-day EMA is 30.46, which makes it a Sell.
-
Janux Therapeutics 50-day exponential moving average is 35.27 while JANX share price is 28.25, making it a Sell technically.
-
JANX stock price is 28.25 and Janux Therapeutics 200-day simple moving average is 40.97, creating a Sell signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.29 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is -2.08, suggesting Janux Therapeutics is a Sell
-
Janux Therapeutics Relative Strength Index (RSI) is 37.42, which suggest Janux Therapeutics is oversold
-
The Bollinger Bands (25) for Janux Therapeutics is (29.01 - 32.01), which suggest Janux Therapeutics is a Sell
-
The Bollinger Bands (100) for Janux Therapeutics is (33.52 - 55.34), which suggest Janux Therapeutics is a Sell
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.